Kobayashi Pharmaceutical Co., Ltd.
4967
Rang în acțiuni
#4483
Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries,... Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan, the United States, Southeast Asia, and internationally. The company offers Ammeltz, an anti-inflammatory pain relief medicine; Dent, an effervescent denture cleaning agent; Ekitai Bluelet Okudake, a toilet bowl cleaner; Naicitol, a Chinese herbal medicine that promotes the breakdown and metabolism of fat; BreathCare, an oral breath freshener capsule; Netsusama sheet, a cooling gel sheet; and deodorizing air fresheners, lens cleaners, and oral hygiene products. It also manufactures and sells pharmaceuticals, fragrances, deodorants, cosmetics, health food, synthetic resin processed products, paper products, and hand warmers; and sells daily necessities. In addition, the company engages in transportation, real estate management, advertising planning and production, sales promotion and market research, promotional goods production and sales, and asset management activities, as well as in pharmacy, retail, and cleaning industries. Kobayashi Pharmaceutical Co., Ltd. was founded in 1886 and is headquartered in Osaka, Japan.
Preț acțiune
$45.65
Capitalizare de piață
$3.39B
Schimbare (1 zi)
-0.40%
Schimbare (1 an)
30.30%
Țară
JP
Tranzacționează Kobayashi Pharmaceutical Co., Ltd. (4967)
Categorie
Consumer Defensive
Raport P/S pentru Kobayashi Pharmaceutical Co., Ltd. (4967)
Raport P/S la data de October 2026 TTM: 3.17
Conform celor mai recente rapoarte financiare și prețului acțiunilor Kobayashi Pharmaceutical Co., Ltd., raportul P/S actual (TTM) este 3.17. La sfârșitul anului 2024, compania avea un P/S de 2.80.
Istoricul raportului P/S pentru Kobayashi Pharmaceutical Co., Ltd. din 2005 până în 2026
Raport P/S la sfârșitul fiecărui an
| An | Raport P/S | Schimbă |
|---|---|---|
| 2026 (TTM) | 3.17 | 30.61% |
| 2025 | 2.43 | -12.95% |
| 2024 | 2.80 | -5.80% |
| 2023 | 2.97 | -29.12% |
| 2022 | 4.19 | -7.92% |
| 2021 | 4.55 | -30.53% |
| 2020 | 6.55 | 51.39% |
| 2019 | 4.33 | 22.71% |
| 2018 | 3.53 | -4.20% |
| 2017 | 3.68 | 40.51% |
| 2016 | 2.62 | -4.10% |
| 2015 | 2.73 | 42.68% |
| 2014 | 1.91 | 29.25% |
| 2013 | 1.48 | 14.58% |
| 2012 | 1.29 | 6.86% |
| 2011 | 1.21 | -0.97% |
| 2010 | 1.22 | 15.03% |
| 2009 | 1.06 | 52.50% |
| 2008 | 0.70 | -2.96% |
| 2007 | 0.72 | 2.06% |
| 2006 | 0.70 | 24.74% |
| 2005 | 0.56 | 0.00% |
Raport P/S pentru companii similare sau competitoare
| Companie | Raport P/S | Diferență raport P/S | Țara |
|---|---|---|---|
| 4.28 | 34.75% |
US
|
|
| 4.52 | 42.49% |
FR
|
|
| 3.54 | 11.47% |
US
|
|
| 6.51 | 105.04% |
IN
|
|
| 2.50 | -21.37% |
US
|
